0001346302-20-000083.txt : 20201217 0001346302-20-000083.hdr.sgml : 20201217 20201217164001 ACCESSION NUMBER: 0001346302-20-000083 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201216 FILED AS OF DATE: 20201217 DATE AS OF CHANGE: 20201217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PRESTRELSKI STEVEN CENTRAL INDEX KEY: 0001744027 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38536 FILM NUMBER: 201396565 MAIL ADDRESS: STREET 1: C/O XERIS PHARMACEUTICALS STREET 2: 180 N. LASALLE STREET, SUITE 1800 CITY: CHICAGO STATE: IL ZIP: 60601 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: XERIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001346302 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 203352427 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 180 NORTH LASALLE STREET STREET 2: SUITE 1600 CITY: CHICAGO STATE: IL ZIP: 60601 BUSINESS PHONE: 844-445-5704 MAIL ADDRESS: STREET 1: 180 NORTH LASALLE STREET STREET 2: SUITE 1600 CITY: CHICAGO STATE: IL ZIP: 60601 4 1 wf-form4_160824118672311.xml FORM 4 X0306 4 2020-12-16 0 0001346302 XERIS PHARMACEUTICALS INC XERS 0001744027 PRESTRELSKI STEVEN C/O XERIS PHARMACEUTICALS, INC. 180 N. LASALLE STREET, SUITE 1600 CHICAGO IL 60601 0 1 0 0 Chief Scientific Officer Common Stock 2020-12-16 5 G 0 E 10000 0 D 426824 D /s/ Beth Hecht, Attorney-in-Fact 2020-12-17